1 Schlegel M, Osterwalder JJ, Galeazzi RL, Vernazza PL. Comparative efficacy of three mumps vaccines during disease outbreak in Eastern Switzerland: cohort study. BMJ. 1999;319(7206):352.
2 Bundesamt für Gesundheit SKfI. Prävention von Masern, Mumps und Röteln. Richtlinien und Empfehlungen (ehemals Supplementum XII) 2003.
3 Prevention CfDCa. Chapter 9: Mumps. Manual for the surveillance of vaccine-preventable diseases 2008.
4 Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ. 2005;330(7500):1132–5.
5 Hviid A, Rubin S, Muhlemann K. Mumps. Lancet. 2008;371(9616):932–44.
6 Dejucq N, Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev. 2001;65(2):208–31 ; first and second pages, table of contents.
7 Werner CA. Mumps orchitis and testicular atrophy; a factor in male sterility. Annals of internal medicine. 1950;32(6):1075–86.
8 Enders M, Rist B, Enders G. Frequency of spontaneous abortion and premature birth after acute mumps infection in pregnancy. Gynakologisch-geburtshilfliche Rundschau. 2005;45(1):39–43.
9 Sane J, Gouma S, Koopmans M, et al. Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012. Emerging infectious diseases. 2014;20(4):643–8.
10 Bruyn HB, Sexton HM, Brainerd HD. Mumps meningoencephalitis; a clinical review of 119 cases with one death. California medicine. 1957;86(3):153–60.
11 Benito RJ, Larrad L, Lasierra MP, Benito JF, Erdociain F. Persistence of specific IgM antibodies after natural mumps infection. The Journal of infectious diseases. 1987;155(1):156–7.
12 Jent P, Olah A, Sommerstein R. Third Dose of MMR Vaccine for Mumps Control. The New England journal of medicine. 2017;377(24):2402.
13 Marin M, Marlow M, Moore KL, Patel M. Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak. MMWR Morbidity and mortality weekly report. 2018;67(1):33–8.
14 Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. The New England journal of medicine. 2008;358(15):1580–9.
15 Barskey AE, Schulte C, Rosen JB, et al. Mumps outbreak in Orthodox Jewish communities in the United States. The New England journal of medicine. 2012;367(18):1704–13.
16 Gouma S, Sane J, Gijselaar D, et al. Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009–2012). The Journal of general virology. 2014;95(Pt 5):1074–82.
17 Rubin SA, Qi L, Audet SA, et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. The Journal of infectious diseases. 2008;198(4):508–15.
18 Cohen C, White JM, Savage EJ, et al. Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerging infectious diseases. 2007;13(1):12–7.
19 Cardemil CV, Dahl RM, James L, et al. Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control. The New England journal of medicine. 2017;377(10):947–56.
20 Lewnard JA, Grad YH. Vaccine waning and mumps re-emergence in the United States. Science translational medicine. 2018;10(433).
21 Fiebelkorn AP, Coleman LA, Belongia EA, et al. Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine. Open forum infectious diseases. 2014;1(3):ofu094.